2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments

Please join our experienced panel for a review of key takeaways from the FDA’s 2021 drug and device advertising and promotion enforcement letters and a discussion of related regulatory developments. Learn the issues that were most commonly cited, as well as other important legal and regulatory developments, and what these could mean for your business. Panelists will discuss:

• 2021 drug and device advertising and promotion enforcement overview

• Regulatory agendas, priorities and research initiatives

• Predictions for what may be expected in 2022

If you have questions concerning this roundtable webinar, email Chayako Williams at cbwilliams@kslaw.com.

CLE

King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: transitional/appropriate for newly admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, garias@kslaw.com. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.